Open Access Article
Zhuan Zou†
b,
Shuhan Jiang†a,
Wenjin Chen†c,
Yilong Wanga,
Qu Liangd,
Wei Fangd,
Xinli Zhan*b,
Ronghe Gu
*d and
Quanzhi Chen*ae
aSchool of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi, P. R. China. E-mail: quanzhi_chen@163.com
bDepartment of Spine and Osteopathic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, P. R. China. E-mail: zhanxinli@stu.gxmu.edu.cn
cPediatric Dentistry Department, College & Hospital of Stomatology, Guangxi Medical University, Nanning 530021, Guangxi, P. R. China
dDepartment of Spine Surgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, P. R. China. E-mail: nnsygrh@sr.gxmu.edu.cn
eUniversity Engineering Research Center of Advanced Technologies in Medical and Biological Intelligent Manufacturing, Guangxi Medical University, Nanning 530021, Guangxi, P. R. China
First published on 23rd April 2026
To elucidate the mechanism underlying micro-arc oxidation (MAO) coatings in bone regeneration, biomimetic coatings with different surface roughness were fabricated on titanium alloy substrates via MAO, and their effects on osteogenic differentiation and mechanotransductive signaling were investigated. The prepared hydroxyapatite (HA)-containing MAO coating exhibited a porous micro-nano structure, with porosity and micro-roughness ranging from 28.1% to 38.6% and 9.3 to 15.8 µm, respectively. Cell experiments demonstrated that the coating with a porosity of 35.6% and a roughness of 15.8 µm significantly promoted cell adhesion, proliferation, and osteogenic differentiation (with a 76.0% increase in alkaline phosphatase activity relative to the NC group), while upregulating the expression of downstream target genes YAP1, Runx2 and OCN. Micro-CT results revealed that the 500 V coating group exhibited a 30.9% increase in bone volume fraction and an 81.3% elevation in trabecular thickness relative to the NC group, with the bone-implant contact ratio showing a corresponding 44.6% enhancement. Histological analysis further confirmed that the elevated porosity and surface roughness facilitated the tight encapsulation of the porous coating structure by newly formed bone tissue. Bond strength testing revealed that the 500 V coating group achieved an interfacial bond strength of 33.2 N after 42 days in vivo, representing a 55.87% increase compared with the NC group. This study elucidated the influence of surface roughness on osseointegration, providing a theoretical basis for optimising the surface microstructure of implant materials.
Micro-arc oxidation (MAO) technology enables the in situ fabrication of TiO2-dominated micro/nano composite ceramic coatings on titanium alloy surfaces, holding substantial promise for orthopedic implant applications.8 Such coatings feature a three-dimensional interconnected porous network featuring coexisting micrometer-scale primary pores and nanoscale secondary structures, which biomimetically recapitulate the physical niche of the native bone extracellular matrix.9,10 Previous studies reported that MAO coatings with a biomimetic trabecular topology with 65% porosity and ∼600 µm equivalent pore size more effectively promoted osteoblast adhesion, proliferation and differentiation.11,12 Experiments using beagle mandibular implants further revealed that the MAO coating exhibited significantly enhanced peri-implant new bone formation, higher bone-implant contact (BIC) rates, and tighter interface bonding.13,14 This coating architecture also provides a foundational strategy for the structure-function synergistic optimization in bone defect repair.15,16 The porous structure enlarges the specific surface area, facilitating the adsorption and conformational unfolding of adhesion proteins such as fibronectin, promoting nutrient and metabolite transport, and providing stable anchoring for cells, thereby significantly enhancing the adhesion, spreading, proliferation and osteogenic differentiation of BMSCs.17–19 Furthermore, improving coating hydrophilicity,20 adjusting surface charges, or regulating the chemical microenvironment via doping with osteogenic ions (such as Ca, P, Sr) or loading bioactive agents (e.g., BMP-2, antibiotics) can synergistically boost coating bioactivity and anti-infective performance.21,22 These modifications guided MC3T3-E1 cells to form elongated pseudopodia, acquire a well-spread morphology, and develop dense stress fibers, optimizing mechanical coupling between cells and the scaffold and laying a structural basis for osteogenic signaling activation.23–25 However, current research remains largely confined to the “structure-phenotype” correlation level, and few systematic studies have elucidated the mechanisms underlying osteogenic differentiation by exploring how the local microenvironment (encompassing coating composition and topography) modulates cellular mechanosensitivity.
Biomechanical cues serve as key regulators of cell fate specification and have garnered increasing attention.26 In addition, mechanical stress can regulate cellular behavior by activating mechanical transduction signaling cascades. Among these, YAP1 (Yes-associated protein 1), the core effector of the Hippo pathway, undergoes dynamic nucleocytoplasmic shuttling in response to varying mechanical stimuli.27 Specifically, nuclear YAP1/TAZ acts as a transcriptional co-activator to drive the expression of downstream target genes, thereby governing cell proliferation, differentiation, survival, and migration, and plays an essential role in regulating osteogenic differentiation.28 Studies have demonstrated that rough surfaces, patterned structures, and fibrous substrates can significantly enhance osteogenic differentiation by promoting nuclear translocation and activation of YAP/TAZ.29 For instance, optimal YAP/TAZ activation and osteogenesis were achieved on hydroxyapatite disks with a surface roughness of 0.77–1.09 µm and a peak distance of 39.3–53.9 µm.30 Similarly, grid-like PDMS micropatterns enhanced YAP activation and osteogenic differentiation in MC3T3-E1 preosteoblasts.31 Specific nanopatterns (70 nm and 200 nm) have also been shown to promote osteogenesis via TAZ activation in human mesenchymal stem cells.32 However, the molecular mechanisms by which the surface characteristics of micro-arc oxidation (MAO) coatings regulate bone regeneration via mechanotransduction pathways remain poorly understood.
In this study, biomimetic porous coatings with gradient roughness were fabricated on titanium alloy surfaces via MAO technology, and the regulatory effects of surface architecture on BMSCs adhesion, spreading, proliferation, and osteogenic differentiation were systematically explored. We employed a multiscale analysis that integrated in vitro cellular mechanoresponses (proliferation, F-actin cytoskeletal remodeling, and YAP1 nuclear translocation) with in vivo osseointegration efficiency, to provide an in-depth analysis of the molecular mechanisms underlying the MAO coating structure and osteogenic differentiation. This study would provide a theoretical basis for promoting MAO modification of titanium alloy implant surfaces.
For cytotoxicity analysis, the third-generation BMSCs (1.0 × 104 cells per well) were seeded onto the coating surfaces, which were then placed in 24-well plates. Co-cultured for 48 h, the medium was carefully removed, and the cells were stained with the Live/Dead staining kit (Invitrogen, USA) for 15 min under light-protected conditions. Finally, a fluorescence microscope (Zeiss, Germany) was utilized to observe and document the samples.
For cell proliferation assays, third-generation BMSCs were inoculated onto the different coating surfaces in a 24-well plate at a density of 1.0 × 104 cells per well. The cells were then incubated in a cell incubator for 1, 3, and 5 days, respectively. After each incubation period, the culture medium was carefully aspirated and discarded. The wells were washed three times with PBS, after which 500 µL of complete culture medium supplemented with 10% CCK-8 solution (NCM Bio, Suzhou, China) was added to each well. The 24-well plate was placed back into the incubator for 4 h to ensure complete reaction stability. Subsequently, 200 µL of the reaction solution from each well was transferred to a 96-well plate, and the absorbance values at a wavelength of 450 nm were measured using an enzyme-labeled instrument (Biotek, USA).
For cytoskeleton observation, samples were placed in a 24-well plate, and BMSCs were seeded onto the coating surface at an density of 1 × 104 cells/well. After 48 h of co-culture, the cells were washed with PBS and fixed using 4% paraformalde. Cells were osmotically stabilised by treatment with 0.2% Triton X-100 in PBS for 5 min, then incubated in the dark at 4 °C for 12 h with an appropriate volume of rhodamine-labeled phalloidin (5 units per mL) diluted in PBS. After rinsing with PBS, cell nuclei were stained with Hoechst 33
258 at 4 °C for 10 min. Following a final wash with PBS, the cells were observed and imaged using a fluorescence microscope (Zeiss, Germany).
000×g for 15 min at 4 °C to collect the supernatant. The protein concentration of the cell lysate was determined using a BCA Protein Assay Kit (Beyotime, China). The activities of ALP and YAP1 were detected using rat ALP ELISA Kit and rat YAP1 ELISA Kit (both from Beyotim, China) according to the kit instructions. The absorbance value at 405 nm was measured using a microplate reader, and the activity levels of ALP and YAP1 were calculated based on the standard curves, normalized to the total protein concentration of the cell lysate.
000×g for 15 min at 4 °C. The upper aqueous phase was transferred to a new centrifuge tube, and an equal volume of isopropanol was added, mixed gently, and incubated at room temperature for 10 min, then centrifuged at 12
000×g for 10 min at 4 °C to precipitate RNA. The RNA pellet was washed twice with 75% ethanol (prepared with DEPC water), centrifuged at 7500×g for 5 min at 4 °C, air-dried at room temperature for 5–10 min, and dissolved in 20 µL RNase-free water. The concentration and purity of total RNA were determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA).Reverse transcription was performed using 1 µg of total RNA with the All-in-One qRT Master Mix II (Yunbio, China), which included a genomic DNA elimination step. The reaction system (20 µL total volume) consisted of 1 µg total RNA, 5 µL of 5× gDNA Eliminator Buffer, 2 µL of 5× PrimeScript Buffer, 1 µL of PrimeScript RT Enzyme Mix, and nuclease-free water. The thermal cycling conditions were: 37 °C for 15 min for reverse transcription, 85 °C for 5 s for enzyme inactivation, and held at 4 °C. The resulting cDNA was diluted 10-fold with nuclease-free water prior to qPCR amplification.
qPCR was carried out on ABI 7500 system using 2×Q3 SYBR qPCR Master Mix(Universal). The specific primer sequences for Runx2, OCN, and the reference gene GAPDH are listed in Table 1. The thermal cycling protocol involved an initial denaturation at 95 °C for 30 s, followed by 40 cycles of 95 °C for 5 s and 60 °C for 30 s. Melting curve analysis was performed to verify primer specificity. Relative gene expression was calculated using the 2−ΔΔCt method, with GAPDH as the internal control. The expression level in the NC group was normalized to 1.0. All experiments were performed in triplicate.
| Target gene | Primer sequence (5′–3′) |
|---|---|
| Runx2-forward primer | CAACTTCCTGTGCTCCGTGC |
| Runx2-reverse primer | CATGACGGTAACCACGGTCC |
| OCN-forward primer | AGGACCCTCTCTCTGCTCACT |
| OCN-reverse primer | CTATTCACCACCTTACTGCCC |
| GAPDH-forward primer | CAAGATGGTGAAGGTCGGTG |
| GAPDH-reverse primer | TGCCGTGGGTAGAGTCATACTG |
000 U per kg) was intramuscularly injected once a day for 3 consecutive days to prevent infection, and the wound healing was monitored daily.(1) At each time point, the right femur with the implant was harvested, the soft tissue was removed carefully, and part of the samples were used for micro-CT scanning and push-out mechanical testing.
(2) At 4 weeks post-implantation, an additional 3 rats per group were sacrificed to harvest the liver tissue (for biosecurity evaluation) and the femoral implant samples (for histological and immunohistochemical analysis).
Postoperative bone specimens were collected at 4 weeks, subjected to graded dehydration and resin embedding, followed by preparation of 5 micrometre-thick hard tissue sections. Histological analysis: sections underwent haematoxylin and eosin (HE) staining, with observation under light microscopy of new bone formation and tissue integration at the bone-implant interface. Immunohistochemical analysis: following dewaxing, sections were incubated overnight at 4 °C with primary antibodies targeting YAP1, Runx2, and OCN, followed by incubation at room temperature for 30 minutes with corresponding secondary antibodies. Sections were then stained with DAB and counterstained with haematoxylin. Positive expression was observed under light microscopy, and the area of positive expression was quantified using Image-Pro Plus software.
The push-out test was employed to evaluate the bond strength at the bone-implant interface: using an Instron 5548 electronic universal testing machine, the maximum load at which the implant separated from the bone tissue was determined at a loading rate of 1 mm min−1. This value served as a quantitative indicator of the interface bond strength.
| Coatings | Ti | O | Ca | P | Si |
|---|---|---|---|---|---|
| 400V | 36.7 | 55.9 | 0.4 | 1.3 | 5.3 |
| 450V | 36.5 | 55.5 | 0.5 | 2.1 | 5.4 |
| 500V | 36.4 | 54.9 | 0.6 | 2.2 | 5.7 |
Quantitative analysis of the coating microscopic roughness (Fig. 1g–j) revealed that the surface roughness (Ra) increased in a gradient manner with the increase of voltage: the Ra values of 400 V, 450 V, and 500 V coatings were 9.3 µm, 12.5 µm, and 15.8 µm, respectively. The 3D topographic images of AFM clearly showed that the surface undulation of the coatings was intensified with the increase of voltage, and the 500 V coating presented a more prominent pitted structure, which was consistent with the SEM observation results of the porous structure evolution. Quantitative analysis of coating porosity (Fig. 1l) showed that the porosity was positively correlated with the preparation voltage, increasing from 28.1% (400 V) to 38.6% (500 V). In addition, the coating thickness also exhibited a voltage-dependent increase trend, rising from 10.3 µm (400 V) to 15.6 µm (500 V) (Fig. 1n).
Surface wettability analysis results (Fig. 1m) revealed that the hydrophilicity of the coatings was significantly enhanced with the increase of MAO voltage. The contact angles of 400 V, 450 V and 500 V coatings were 17.4°, 16.8° and 16.3°, respectively. The contact angles of all coatings were close to the superhydrophilic level (<20°), which could effectively promote the subsequent cell adhesion and biological response.
XRD analysis (Fig. 2) revealed that all MAO coatings exhibited characteristic diffraction peaks of anatase and rutile TiO2. The 500 V coating exhibited a relatively higher rutile phase content, suggesting that elevated voltage enhanced thermal effects and oxygen vacancy formation, thereby facilitating TiO2 phase transformation.
High-resolution XPS analysis was further used to characterize the chemical bonding states of Ca, P, O elements in the MAO coatings (Fig. 3), to clarify the composition and structural characteristics of the coatings at the molecular level. The Ca 2p spectra of all coatings exhibited a double-peak structure of Ca 2p3/2 and Ca 2p1/2, and the binding energy positions and peak shapes were consistent with the Ca-PO4 bonding in hydroxyapatite (HA), indicating that the Ca element in the coatings existed in the form of calcium phosphate. The P 2p spectra presented double peaks of P 2p3/2 and P 2p1/2, corresponding to the characteristic peaks of PO43−, confirming the presence of phosphate in the coatings. The O 1s spectra could be fitted into three characteristic peaks, which were assigned to Ti–O bonding (TiO2 matrix), –OH hydrophilic groups and PO43− bonding (calcium phosphate), respectively. These results confirmed that the MAO coatings prepared in this study were composite structures composed of TiO2 ceramic matrix and in situ deposited HA.
![]() | ||
| Fig. 4 CCK-8 proliferation assay of BMSCs cultured on different MAO coatings (*P < 0.05, **P < 0.01). | ||
Live/dead staining results obtained at 48 hours post-seeding showed that the NC group displayed poor cell morphology and low cell density. In contrast, all three MAO coating groups exhibited numerous viable cells labeled with green fluorescence, accompanied by only faint red fluorescent signals indicating dead cells (Fig. 5). No significant differences in cell viability were observed among the three coating groups. This indicated that MAO coatings with varying roughness exhibit favourable cytocompatibility and no obvious cytotoxicity, thus providing a biocompatible interface for cell growth and function.
Rhodamine-phalloidin staining results (Fig. 6) revealed that BMSCs exhibited favourable spreading morphology on the 500 V coating surface, and F-actin filaments displayed dense and orderly arrangement, forming robust and distinct stress fibre bundles. Nevertheless, the F-actin cytoskeleton within cells on the 400 V (Fig. 6) and 450 V coating (Fig. 6) was relatively sparse, exhibiting a lower degree of stress fibre development. Combined with SEM analysis, the porous micro-nano structure and microenvironment with higher surface roughness of the 500 V coating effectively promoted cytoskeletal reorganisation and enhanced adhesion at the cell–material interface.
![]() | ||
| Fig. 6 Rhodamine-phalloidin staining of BMSCs cultured on different samples (400 × ): (a) NC group, (b) 400 V coating, (c) 450 V coating, (d) 500 V coating. | ||
qPCR assays were performed to quantify the expression of osteogenic genes in BMSCs after 14 days of co-culture with MAO coatings, and the results (Fig. 7a and b) revealed that osteogenic gene expression was upregulated in a porosity- and roughness-dependent manner across all experimental groups. Notably, the 500 V coating group exhibited the most prominent osteogenic induction effect: RUNX2 expression was upregulated to 3.27-fold that of the NC group, corresponding to a 221% increase, while OCN expression reached 6.83-fold that of the NC group (a 499% increase) and was 68% higher than that of the 450 V coating group. RUNX2 acts as a master transcription factor regulating early osteogenic differentiation,32 and OCN serves as a late-stage marker associated with osteogenic maturation and bone matrix mineralization.33 The results in Fig. 7c further confirmed that higher porosity and roughness significantly promote the osteogenic differentiation of BMSCs on MAO coating surfaces. The ALP activity of BMSCs increased in a gradient manner with increasing roughness of the MAO coating: The 500 V coating group showed a 76% increase in ALP activity compared to the NC group, and 45.2% and 15.1% higher than the 400 V and 450 V coating groups, respectively.
As a core mechanosensitive transcriptional co-activator of the Hippo pathway, YAP1 activity is dynamically modulated by cytoskeletal tension and extracellular matrix stiffness. Within a stiff ECM, YAP1 undergoes dephosphorylation and nuclear translocation, activating osteogeneic transcriptional programs that direct mesenchymal stem cells toward osteogenic differentiation.34,35 Analysis of YAP1 expression levels (Fig. 7d) revealed a gradient upregulation with increasing preparation voltage, peaking at 0.47 in the 500 V coating group. These results indicated that the high porosity and micro/nano-scale roughness of the coating enhanced mechanical coupling at the cell–material interface, elevated cytoskeletal tension, and thereby synergistically upregulated the expression of key osteogenic factors.
To investigate the mechanotransduction signaling regulation of BMSCs on different coatings, we analyzed the subcellular localization of the core mechanotranscription factor YAP1 using immunofluorescence staining. BMSCs were cultured on NC, 400 V, 450 V, and 500 V coating groups for 7 days, and the localization of YAP1 was observed (Fig. 8). In the NC group, cells exhibited poor spreading, and YAP1 was mainly distributed in the cytoplasm. With increasing coating porosity and surface roughness, cell spreading was significantly improved, accompanied by progressive nuclear translocation of YAP1. Notably, the 500 V group showed the most extensive cell spreading and the strongest YAP1 nuclear accumulation, indicating that the porous bionic microstructure effectively activates YAP1-mediated mechanotransduction and promotes osteogenic differentiation.
![]() | ||
| Fig. 8 Immunofluorescence staining of F-actin (red), YAP1 (green), and nuclei (blue) in BMSCs cultured on different samples for 7 days. | ||
![]() | ||
| Fig. 9 Hepatic tissue HE staining sections for safety evaluation of different coatings in SD rats (100 × ): (a) NC group, (b) 400 V coating, (c) 450 V coating, (d) 500 V coating. | ||
Bone regeneration and osseointegration in a rat femoral defect model were assessed by X-ray, micro-CT 3D reconstruction, and quantitative analysis. Fig. 10a shows the femoral defect site, with obvious bleeding at the wound margin, indicating that the surgical procedure was performed in accordance with standard protocols. Fig. 10b and c presents radiographic images taken at 6 weeks post-surgery, clearly delineating the bone defect area and implant position. Surrounding regions exhibit high-density bone formation (yellow circles), indicating new bone formation and mineralisation and confirming favourable osseointegration. The 3D reconstruction in Fig. 10d demonstrates that at 2 weeks post-surgery, all implant groups exhibited limited new bone growth within the coating pores. The 500 V coating group showed more uniform new bone distribution, whereas the NC group exhibited less new bone formation. By week 4, bone regeneration accelerated markedly, with distinct bone bridges forming in the 400 V and 450 V coating groups. The 500 V coating group exhibited the largest bone volume and the most compact structure. By week 6, the 500 V coating group achieved complete fusion at the bone-implant interface with an intact trabecular network, whereas residual unhealed gaps remained in the other groups.
To evaluate the in vivo osteogenic performance and osseointegration capability of the porous bionic coatings, the quantitative morphometric parameters are summarized in Fig. 10e–i. The bone volume fraction (BV/TV), a direct indicator of new bone formation at the bone defect site, demonstrated a significant and time-dependent increase in all groups (Fig. 10e). At the 6 weeks endpoint, the BV/TV for the NC group was ∼25.9%. In stark contrast, the implant groups with porous bionic coatings exhibited markedly enhanced bone regeneration, with values of ∼28.2% (400 V coating), ∼31.8% (450 V coating), and ∼33.9% (500 V coating). This corresponds to a 30.9% increase in bone volume for the 500 V coating group compared to the NC group, highlighting its superior osteoinductive potential. The trabecular thickness (Tb.Th) in the 500 V coating group reached approximately 0.29 mm at 6 weeks, representing an 81.3% increase relative to the NC group (approximately 0.16 mm), indicating the formation of a denser and mechanically more functional bone network (Fig. 10f). The bone surface/bone volume ratio (BS/BV) followed a similar trend, with the 500 V coating group showing the highest value (∼29.4 mm−1 at 6 weeks), reflecting a complex and highly interconnected new bone matrix that was conducive to vascularization and nutrient exchange (Fig. 10g). Concurrently, the trabecular number (Tb.N) was also elevated in the 500 V coating group (∼3.5 mm−1 vs. ∼2.6 mm−1 for NC group at 6 weeks), indicating a denser trabecular structure (Fig. 10h). The higher Tb.N indicates that the 500 V coating group had greater trabecular density and a more compact microstructure, thereby optimizing stress transfer and improving fatigue resistance. The bone-implant contact ratio (BIC%) is a gold-standard metric for evaluating osseointegration, and the results showed a pronounced improvement in the coating groups (Fig. 10i). By 6 weeks, the BIC% for the NC group reached ∼47.3%, whereas the 500 V coating group achieved a significantly higher value of ∼68.4%, representing a 44.6% enhancement. The elevated BIC in the 500 V coating group stems from the formation of a HV-enriched oxide layer on its surface. This layer enhanced surface energy and hydrophilicity, facilitating the release of key ions such as Ca2+.
The interfacial bond strength at the bone-implant interface was quantitatively measured by push-out testing at 14, 28, and 42 days post-implantation in a rat femoral defect model. Results (Fig. 11) demonstrated that the interfacial bond strength in all experimental groups increased significantly with implantation time, consistent with the dynamic bone-implant integration process: fibrous tissue formation, new bone deposition, and subsequent mature bone remodeling.28 Among these, the 500 V coating group demonstrated the most outstanding performance: at 14 days, the bond strength reached 12.6 N, significantly higher than that of the NC group (6.6 N) and other coating groups; by day 42, it had increased to 33.2 N, representing a 164% rise from baseline and exceeding that of the 450 V coating group (28.7 N), 400 V coating group (24.6 N), and NC group (21.3 N). Crucially, the bond strength increment (11.4 N) in the 500 V coating group between day 28 and 42 was markedly higher than in other groups, suggesting a sustained and enhanced osteogenic effect during the mid-to-late stages of osseointegration. This was primarily attributable to the synergistic effect of coating optimised pore size distribution and the presence of bioactive functional groups (specifically the –OH and –PO43− groups contained within hydroxyapatite).
![]() | ||
| Fig. 11 Dynamic changes in interfacial bonding strength during osseointegration for different samples (*P < 0.05, **P < 0.01). | ||
Fig. 12 shows the HE staining of bone tissue and expression analysis of osteogenic differentiation-related proteins (YAP1, RUNX2, OCN) at 4 weeks post-implantation. Grayscale quantitative analysis was performed on the magnified images, as shown in Fig. 12a–c. HE staining results revealed that the bone tissue structure in the NC group remained relatively intact, although new bone formation was minimal. In the experimental group, the area of new bone formation gradually increasing voltage, and was most prominent in the 500 V coating group. This indicated that a higher voltage increased coating porosity, and the three-dimensional pores on the implant surface facilitating bone tissue regeneration.
OCN and RUNX2 protein expression was mainly localized in the bone tissue in the NC group. However, new bone formation around the defect site increased with increasing voltage. Analysis of YAP1- positive signal intensity across groups revealed that the NC group exhibited the lowest expression level, with fewer positive cells and sparse distribution. As the applied voltage increased, the number of YAP1-positive cells increased, and these cells were mainly distributed at the margins of the newly formed bone tissue. Among all groups, the 500 V group demonstrated the strongest YAP1 expression and the highest density of positive cells, which were extensively distributed within bone trabeculae and osteoblast regions. This result indicated that appropriate porosity promotes the osteogenic differentiation of BMSCs, consistent with the findings from in vitro experiments.
In vitro cellular experiments demonstrated that all MAO coatings possessed excellent cytocompatibility and no obvious cytotoxicity. Compared with the NC group, BMSCs adhesion, spreading and proliferation were significantly improved on MAO coatings, especially in the 500 V group. The high roughness, interconnected porosity and superhydrophilicity promoted adhesion protein adsorption and provided abundant anchoring sites, facilitating cytoskeletal remodeling and the formation of dense stress fibers.36 These structural changes strengthened mechanical coupling at the cell–material interface and elevated cytoskeletal tension, which is a prerequisite for mechanotransduction activation.37
Osteogenic evaluation revealed that Runx2, OCN and ALP activity were gradually upregulated with increasing coating roughness and porosity, with the 500 V group showing the strongest induction. Higher coating porosity, together with the presence of HA, contributes to enhanced osteogenic differentiation efficiency, which is consistent with previous reports.38 Immunofluorescence confirmed that high roughness and porosity triggered obvious YAP1 nuclear translocation, while YAP1 expression was significantly elevated and positively correlated with osteogenic differentiation.39 Nevertheless, this study investigated the underlying molecular mechanisms in the more complex surface environment of MAO coating. These results indicated that the Hippo–YAP1 pathway serves as the core mechanotransduction axis: surface topography elevates cytoskeletal tension, promotes YAP1 dephosphorylation and nuclear accumulation, and further activates the transcription of Runx2 and OCN, ultimately driving BMSC osteogenic differentiation.
In vivo animal experiments validated that MAO coatings, particularly the 500 V group, significantly enhanced bone regeneration, bone-implant contact and interfacial bonding strength. Micro-CT showed markedly increased BV/TV, BMD and trabecular number, while push-out tests confirmed stable interface bonding. Histological observations demonstrated new bone tissue grew into the porous structure and tightly encapsulated the coating, forming a mechanical interlocking effect.40 Meanwhile, liver tissue HE staining confirmed good biological safety without systemic toxicity.
In summary, this study revealed that voltage-tunable MAO coatings regulate BMSC fate and osseointegration through the surface topography-cytoskeleton tension-YAP1-osteogenic differentiation axis. The 500 V coating with high roughness, high porosity and bioactive HA composition optimizes the implant microenvironment, effectively promotes bone integration and improves interface mechanical stability, providing a reliable theoretical and experimental basis for surface modification of orthopedic titanium implants.
Footnote |
| † These authors contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2026 |